At BELLUS, we are focused on advancing novel therapeutics for conditions with high unmet medical need. Read More

At BELLUS, we are focused on advancing novel therapeutics for conditions with high unmet medical need. Read More

Blog

February 9, 2018 BELLUS Health in a Volatile Market
Watching the markets fluctuate over the last few days, I am very grateful that we completed a $20M financing in December that: increased our cash runway to two+ years and through multiple important business milestones; included a wide spectrum of investors which diversifies our shareholder base involved significant participation from validating investors, including insiders and sophisticated...
Read More
October 25, 2017 Editorial: Progress Report: Canada’s Gilead of the North
About 2 ½ years ago, I wrote a post that made a bold prediction that Canada would have at least one fully integrated biotech company by 2025. My arguments included the increasing support from Canadian investors (particularly venture capital), aspirational Canadian management teams and the ability of specialty drugs to provide launching platforms for such companies. Following the listing of...
Read More

Share this

Sign up for email alerts

Email Address *
 
Enter the code shown above.